Intensive glucose control and cardiovascular disease in type 2 diabetes - Should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials

Peter Gæede*

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftLederForskningpeer review

    OriginalsprogEngelsk
    Sider (fra-til)619-621
    Antal sider3
    TidsskriftPolskie Archiwum Medycyny Wewnetrznej
    Vol/bind118
    Udgave nummer11
    StatusUdgivet - 1 jan. 2008

    Citationsformater